To all cluster members interested in initiating and improving their business relationships and market access in China:
According to our latest study “Biotechnology and Pharmaceutical Industry in the European Metropolitan Region Munich (EMM) 2021”, 34% of the companies surveyed are already active in China, 51% are interested in the Chinese healthcare market.
In order to optimize our services and to get a better understanding of your needs regarding collaboration with Chinese partners and access to the Chinese market, we kindly ask you to answer the following questions (ca. 2 min). Even if you don't have a concrete plan at the moment, this survey may stimulate new business ideas and strategic decisions for your company. Thank you for your participation and valuable input.